The National Agency for Food and Drug Administration and Control (NAFDAC), has implored importers, distributors, and consumers to discontinue the sale and use of Lefin Pediatric Suspension drug with immediate effect. The agency, on Sunday in a public alert, also asked consumers to hand over the remaining stock of the drug to the nearest NAFDAC office.  According to the alert, NAFDAC has been informed by Drug Regulatory Authority of Pakistan (DRAP) about a recent recall of Lefin Pediatric Suspension manufactured by M/S Leama Chemi Pharma (PVT) Limited for being substandard. The alert disclosed that Lefin Pediatric suspension is a brand of Paracetamol used for the relief of mild to moderate pain such as headache, muscle aches, toothache as well as pain caused by cold, flu, and sprains.  Health professionals and patients are also encouraged to report adverse events or quality problems experienced with the use of these medicines to the nearest NAFDAC office.